Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

StrainX Bioworks

Explore full profile

Sustainable biomolecules via precision fermentation for various industries.

Bhopal, IndiaFounded 2023Health
Valuation $0–100M Latest valuation · 2026
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for StrainX Bioworks and the history behind them.

About StrainX Bioworks

StrainX Bioworks is a synthetic biology company leveraging precision fermentation to produce high-value biomolecules for the food, nutraceutical, and beauty industries. The company was founded in 2023 by Akshay Mittal (CEO) and Dr. Alok Malaviya (CTO), both alumni of IIT Delhi. After operating in stealth mode for two years to build its integrated biotechnology platform, StrainX has emerged with significant capabilities in strain engineering, fermentation processes, and product development. The firm's core technology revolves around engineering microorganisms, such as bacteria and yeast, to create alternative proteins, enzymes, and bioengineered metabolites sustainably and at scale. This approach reduces reliance on traditional animal or plant-based sourcing. StrainX serves business-to-business (B2B) clients, including global food and beverage companies and ingredient suppliers, by offering clean-label solutions and functional ingredients that enhance taste, texture, and nutrition. Its business model is built on an integrated platform that handles the entire process from technology development and scale-up to manufacturing and commercialization. The company has demonstrated fermentation at a 10,000-liter scale and is planning to expand to 100,000-liter operations. Its product applications include functional ingredients for food, health-promoting compounds for nutraceuticals, and innovative actives for cosmetics. In May 2026, StrainX Bioworks announced it had raised $13 million in a funding round co-led by Prime Venture Partners and Leo Capital, with participation from other investors. The capital is intended to expand its R&D capabilities, scale its fermentation infrastructure in Bhopal, and accelerate global commercialization, with initial target markets in India and the US. The company has already received self-affirmed GRAS (Generally Recognized as Safe) status for one of its ingredients in the US. Keywords: synthetic biology, precision fermentation, biomolecules, alternative proteins, strain engineering, sustainable ingredients, food technology, nutraceuticals, microbial fermentation, B2B ingredients, bio-manufacturing, food additives, cosmetic ingredients, clean label solutions, bioactives, enzymes, metabolites, biotechnology, Akshay Mittal, Alok Malaviya.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2023
Headquarters
Bhopal, India
Employees
45
Open positions
None listed
Dealroom signal
52.2/100
Industry
Health
Sector
Health, Synthetic Biology, Alternative Protein, precision fermentation
Business model
Manufacturing
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning StrainX Bioworks.

See all news

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC May 2026 $13M $52M Dholakia Ventures · SunICON · Leo Capital · Good Startup
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

StrainX Bioworks website traffic

Latest recorded traffic for StrainX Bioworks is 2.8K monthly website visits.

Latest monthly visits2.8K
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Leo Capital
  • Prime Venture Partners
  • Dholakia Ventures
  • SunICON
  • Good Startup
  • Sparrow Capital
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇮🇳 India100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about StrainX Bioworks on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See StrainX Bioworks’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.